Jane Street’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-99
Closed -$18K 9516
2023
Q1
$18K Buy
+99
New +$9.3K ﹤0.01% 8665
2022
Q1
Sell
-126
Closed -$21K 10976
2021
Q4
$21K Sell
126
-405
-76% -$123K ﹤0.01% 9785
2021
Q3
$258K Buy
+531
New +$403K ﹤0.01% 8456
2020
Q4
Sell
-47
Closed -$66K 8072
2020
Q3
$66K Buy
47
+10
+27% +$16.1K ﹤0.01% 6860
2020
Q2
$53K Buy
+37
New +$59.1K ﹤0.01% 6859
2019
Q3
Sell
-11
Closed -$259K 5701
2019
Q2
$259K Buy
+11
New +$279K ﹤0.01% 4391

Other funds holding SONM

Jane Street's SONM Position: Q2 2023 in Review

Jane Street sold out of DNA X Inc (SONM) in Q2 2023, closing a stake of 99 shares — an estimated $18K sold.

Jane Street first reported a position in SONM in Q2 2019 and held it in 6 quarters. The position peaked at $259K in Q2 2019. 13 funds tracked by Wall St. Rank hold SONM as of Q2 2023.

  • Jane Street reported no remaining DNA X Inc position as of Q2 2023 after selling out during the quarter.
  • Jane Street sold 99 DNA X Inc shares in Q2 2023, an estimated $18K.
  • Jane Street first reported a position in DNA X Inc in Q2 2019 and held it in 6 quarters.
  • Jane Street's DNA X Inc position peaked at $259K in Q2 2019.
  • 13 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.